Bottom line
How much do MEDX and SCHLX overlap?
51% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 62.0% of MEDX's assets and 43.5% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings MEDX and SCHLX have in common
| Holding | % of MEDX | % of SCHLX | Overlap |
|---|---|---|---|
| Eli Lilly & Co LLY | 18.46% | 13.85% | 13.85% |
| AbbVie Inc ABBV | 8.85% | 4.90% | 4.90% |
| Novartis AG NVS | 6.89% | 2.90% | 2.90% |
| Johnson & Johnson JNJ | 5.59% | 6.19% | 5.59% |
| AstraZeneca PLC AZN | 4.98% | 3.80% | 3.80% |
| Bristol-Myers Squibb Co BMY | 4.42% | 1.50% | 1.50% |
| Merck & Co Inc MRK | 3.96% | 4.85% | 3.96% |
| Amgen Inc AMGN | 3.91% | 2.88% | 2.88% |
| Pfizer Inc PFE | 2.86% | 1.17% | 1.17% |
| Regeneron Pharmaceuticals Inc REGN | 2.06% | 1.43% | 1.43% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in MEDX
- US Bank Mmda - Usbgfs 7 — 9.19%
- Alkermes PLC — 5.53%
- Ionis Pharmaceuticals Inc — 4.53%
- Alnylam Pharmaceuticals Inc — 3.42%
- Biogen Inc — 3.09%
- Gsk Plc — 2.71%
- CRISPR Therapeutics AG — 2.64%
- Beam Therapeutics Inc — 1.51%
- Galectin Therapeutics Inc — 1.14%
- Intellia Therapeutics Inc — 1.12%
- Sandoz Group AG — 0.80%
- Replimune Group Inc — 0.73%
- Vanda Pharmaceuticals Inc — 0.73%
- Haleon PLC — 0.60%
- Lantern Pharma Inc — 0.55%
Only in SCHLX
- UnitedHealth Group Inc — 5.73%
- Thermo Fisher Scientific Inc — 3.46%
- Gilead Sciences Inc — 2.78%
- Intuitive Surgical Inc — 2.69%
- Stryker Corp — 2.61%
- Vertex Pharmaceuticals Inc — 2.45%
- Abbott Laboratories — 2.39%
- Danaher Corp — 2.13%
- Boston Scientific Corp — 2.10%
- McKesson Corp — 2.05%
- Novo Nordisk A/S — 1.73%
- Medtronic PLC — 1.54%
- Cardinal Health Inc — 1.34%
- Cencora Inc — 1.26%
- Roche Holding AG — 1.24%
Asset mix
| Asset type | MEDX | SCHLX |
|---|---|---|
| Stocks | 92.6% | 99.6% |
| Cash & short-term funds | 9.2% | 0.5% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | MEDX | SCHLX |
|---|---|---|
| US | 77.4% | 85.7% |
| CH | 10.3% | 5.2% |
| GB | 8.6% | 3.8% |
| IE | 5.5% | 1.5% |
| DK | — | 1.7% |
| FR | — | 1.0% |
| NL | — | 1.0% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do MEDX and SCHLX overlap?
What stocks do MEDX and SCHLX have in common?
Should I own both MEDX and SCHLX?
Which holds more stocks, MEDX or SCHLX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.